1. Home
  2. VYGR vs XYF Comparison

VYGR vs XYF Comparison

Compare VYGR & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.92

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

XYF

X Financial each representing six

HOLD

Current Price

$5.04

Market Cap

224.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
XYF
Founded
2013
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
224.3M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
VYGR
XYF
Price
$3.92
$5.04
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
783.0K
103.3K
Earning Date
06-10-2026
01-01-0001
Dividend Yield
N/A
11.95%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,135,000.00
N/A
Revenue This Year
$54.19
N/A
Revenue Next Year
$20.22
N/A
P/E Ratio
N/A
$0.90
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$4.63
52 Week High
$5.55
$20.36

Technical Indicators

Market Signals
Indicator
VYGR
XYF
Relative Strength Index (RSI) 46.21 47.58
Support Level $3.60 $4.86
Resistance Level $4.43 $5.06
Average True Range (ATR) 0.33 0.16
MACD 0.01 0.03
Stochastic Oscillator 10.90 78.65

Price Performance

Historical Comparison
VYGR
XYF

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About XYF X Financial each representing six

X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.

Share on Social Networks: